NGS in Viral Safety
What Do Regulators Really Expect?
📅 June 18, 2026
🕘 11:00 EST | 08:00 PST | 17:00 CEST
⏱️ Duration: 30 minutes
The adoption of Next-Generation Sequencing (NGS) for viral safety testing is accelerating, raising a key question: what do regulators expect when NGS replaces or complements traditional methods?
This presentation reviews current regulatory expectations across major agencies and offers practical guidance on integrating NGS into your viral safety strategy.
We will share an overview of current regulatory expectations for NGS in viral safety across major agencies and provide practical advice on how to position NGS within your overall safety strategy.
Drawing on PathoQuest’s experience supporting clients with NGS-based quality control and regulatory interactions, attendees will gain real-life insights on addressing common agency questions, building robust justifications, and ensuring smoother review processes.
Gain perspective on how to better anticipate regulatory dialogue and integrate NGS into a comprehensive viral safety and quality control strategy.
Key Takeaways:
- Current regulatory expectations and levels of acceptance for NGS in viral safety
- Common regulatory questions and how to proactively address them
- Practical insights from PathoQuest’s experience supporting successful agency interactions
🎤 Speaker
Amina Cherif Louazani, PharmD, PhD
Viral Safety and Regulatory Affairs Manager, PathoQuest
Don’t miss this opportunity to gain practical regulatory insights from industry experts.
